Achmea Investment Management B.V. / ABT
Achmea Investment Management B.V.’s Abbott Laboratories Position
Does Achmea Investment Management B.V. own Abbott Laboratories (ABT)? Not currently — the last reported position was 151.8K shares worth $20M in Q3 2025; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$20M
Q3 2025
Shares
151.8K
% of Portfolio
+0.25%
Quarters Held
20
position exited
Position History ABT
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q3 2025 | 151.8K | $20M | +0.25% |
| Q2 2025 | 143.3K | $19M | +0.25% |
| Q1 2025 | 139.0K | $18M | +0.27% |
| Q4 2024 | 96.9K | $11M | +0.18% |
| Q3 2024 | 110.4K | $13M | +0.21% |
| Q2 2024 | 115.3K | $12M | +0.21% |
| Q1 2024 | 114.0K | $13M | +0.25% |
| Q4 2023 | 138.9K | $15M | +0.32% |
| Q3 2023 | 152.9K | $15M | +0.32% |
| Q2 2023 | 150.3K | $16M | +0.35% |
| Q1 2023 | 116.8K | $12M | +0.34% |
| Q4 2022 | 106.4K | $11M | +0.37% |
| Q3 2022 | 101.6K | $10M | +0.35% |
| Q2 2022 | 111.0K | $12M | +0.39% |
| Q1 2022 | 113.1K | $13M | +0.35% |
| Q4 2021 | 103.5K | $15M | +0.69% |
| Q4 2019 | 126.8K | $11M | +0.42% |
| Q3 2019 | 131.1K | $11M | +0.43% |
| Q2 2019 | 141.9K | $12M | +0.46% |
| Q1 2019 | 141.5K | $11M | +0.47% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Achmea Investment Management B.V.’s full portfolio or all institutional holders of ABT.